Project Grant H79TI086426
- Federal Grant Award Summary Odyssey House Louisiana, Inc. received a $5.685 million Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Mental Health Services under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The award, issued on September 30, 2025, with a completion date of September 29, 2027, supports the comprehensive Hepatitis C Free Program, designed to eliminate...
- Federal Grant Award Summary Louisiana State University Health Sciences Center New Orleans received a $225,065 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 15, 2025, with a completion date of July 31, 2027. The award supports research on targeting the renin system as a novel therapeutic approach for managing chronic pain and opioid use disorder (OUD). The project leverages the FDA-approved...
- Federal Grant Award Summary The Naloxone Project (TNP) received a $600,000 Project Grant award effective September 1, 2025, through August 31, 2026, from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912). The COLORADO CHANGE (Coalition for Harm Reduction, Access to Naloxone, and Grassroots Rural Engagement) project addresses the opioid overdose crisis in Colorado's rural communities, where opioids were involved in over 62% of the state's 7,022...
- This $3,000,000 Project Grant award from the Executive Office of the President Office of the National Drug Control Policy (ONDCP) supports the Research and Data Analysis federal grant program (CFDA 95.007). The grant funds nine organizations to deliver community-level intervention initiatives to combat drug overdoses from September 1, 2021 to August 31, 2022. The University of Baltimore receives $3 million to oversee the grant, with specific services delivered through eight sub-awards. These...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $1.2 million Project Grant from the Health Resources and Services Administration (HRSA), Bureau of Health Professionals, under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732). The award, effective July 1, 2025, through June 30, 2030, funds the expansion and operation of OHSU's Addiction Medicine Fellowship (AMF) program, which provides specialized training in addiction...
- Federal Project Grant Award Summary The Health Resources and Services Administration (HRSA) awarded OhioHealth Research Institute $1.2 million through the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732) on July 1, 2025, for a five-year project period extending through June 30, 2030. The award supports the OhioHealth Addiction Medicine Fellowship Program, which trains physicians in comprehensive, evidence-based treatment of substance use disorders (SUD) across...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $2.29 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025, with a completion date of March 31, 2030. This research initiative examines the impact of telehealth expansion on opioid use disorder (OUD) treatment delivery within community health centers (CHCs). The study utilizes nearly a decade of CHC...
- The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...
- Federal Grant Award Summary Pinnacle Treatment Centers, Inc. received a $300,000 project grant from the Health Resources and Services Administration (HRSA) under the Rural Healthcare Services Programs (CFDA 93.912), effective September 1, 2025 through August 31, 2026. The Kentucky Overdose Quick Response Project targets opioid use disorder (OUD) treatment and overdose prevention services in rural Scott County and surrounding areas of Kentucky. The awardee, operating through Recovery Works...
- The New Hampshire Department of Safety was awarded $828,738 under the Substance Abuse and Mental Health Services Projects of Regional and National Significance grant program by the Substance Abuse and Mental Health Services Administration to continue and expand the NH Project FIRST initiative. NH Project FIRST seeks to increase the number of first responders and members of key community sectors trained to respond to licit and illicit drug emergencies, establish a statewide first...
ODYSSEY HOUSE LOUISIANA'S OVERDOSE TREATMENT ACCESS PROGRAM: IPREVENT - ODYSSEY HOUSE LOUISIANA, INC. (OHL) PROPOSES A COMPREHENSIVE OPIOID OVERDOSE ACCESS TREATMENT TRAINING PROGRAM, INCLUDING A TRAINING OF TRAINERS (TOT) PROGRAM, AT THREE HUBS ACROSS LOUISIANA: URBAN CENTERS OF ORLEANS PARISH, AND CALCASIEU PARISH, AND RURAL ST. MARY PARISH. OHL PROJECT STAFF WILL DIRECTLY TRAIN 475 HEALTHCARE AND SOCIAL SERVICES PROVIDERS DURING THE FIVE-YEAR GRANT PERIOD. INCLUDED IN THIS POPULATION OF FOCUS, OHL WILL PROVIDE TOT TRAINING TO 20 ORGANIZATIONS, WHO WILL IN TURN COMMIT TO PROVIDE THE LEARNED EDUCATION TO PEERS AND COLLEAGUES IN THEIR REGIONS. THIS PROGRAM WILL INCLUDE TRAINING FOR A WIDE ARRAY OF HEALTH CARE PROVIDERS, INCLUDING PHARMACISTS, PRESCRIBERS, LICENSED CLINICAL SOCIAL WORKERS, MEDICAL ASSISTANTS, AND LICENSED CLINICAL PROFESSIONAL COUNSELORS, AS WELL AS EMPLOYEES AT ORGANIZATIONS SERVING MARGINALIZED GROUPS OR VULNERABLE POPULATIONS. OHL WILL LEVERAGE ITS LOCAL COMMUNITY CONNECTIONS IN THESE THREE LOCATIONS, AS WELL AS ADDITIONAL STATEWIDE NETWORKS TO EXPAND THE PROJECT'S REACH AND TRAIN AS MANY PROFESSIONALS AS POSSIBLE. PROJECT STAFF WILL INCLUDE A LEAD TRAINER AND ONE ADDITIONAL TRAINER TO CONDUCT SESSIONS VIRTUALLY AND IN-PERSON. THE LEAD TRAINER WILL WORK WITH THE PROJECT DIRECTOR AND PROJECT COORDINATOR, BOTH CURRENTLY EMPLOYED AT OHL, TO DEVELOP AN ENGAGING, EVIDENCE-BASED CURRICULUM. PRESENTATIONS WILL INCLUDE FACTS ABOUT OPIOID USE DISORDERS (OUD), OVERDOSES, FDA-APPROVED OVERDOSE REVERSAL MEDICATIONS (E.G., NALOXONE), AND THE OPIOID EPIDEMIC THROUGH THE FRAMEWORK OF CULTURAL HUMILITY. USING THE MOST RECENT AVAILABLE DATA ON THE OPIOID CRISIS IN LOUISIANA AND MOST CURRENT BEST PRACTICES, PROGRAM STAFF WILL CONVEY THE IMPORTANCE OF UNDERSTANDING THE SCIENCE BEHIND THESE TOPICS. THE LEAD TRAINER AND TRAINER WILL ALSO BE ONBOARDED INTO OHL'S PROGRESSIVE MESSAGING AROUND INCLUSIVE, DESTIGMATIZING LANGUAGE AND OTHER ANTI-BIAS MEASURES, ENSURING THAT TRAINEES WILL BE EMPOWERED TO CONDUCT ESSENTIAL INTERNAL AND EXTERNAL ANTI-BIAS WORK AT THEIR JOBS. ALL SESSIONS WILL ALSO INCLUDE VISUAL AIDS (E.G., POWERPOINT PRESENTATIONS) AND INTERACTIVE SEGMENTS SUCH AS DIGITAL OR PRINTED WORKSHEETS TO ENCOURAGE PARTICIPATION AND RETENTION OF THE LESSONS. OHL WILL ALSO PURCHASE NALOXONE TO DISTRIBUTE TO TRAINEE ORGANIZATIONS AS NEEDED. OHL WILL PROVIDE LINKAGES TO TREATMENT FOR PEOPLE WITH OPIOID USE DISORDERS OR WHO HAVE EXPERIENCED AN OPIOID OVERDOSE. THE AGENCY IS THE LARGEST SUBSTANCE USE DISORDER TREATMENT FACILITY IN LOUISIANA AND HAS MEASURES IN PLACE TO PROVIDE COMPREHENSIVE, COMPASSIONATE OUD TREATMENT TO STATE RESIDENTS, WHETHER ON-SITE OR THROUGH LOCAL PARTNERS. THESE SERVICES ARE VITAL TO THE HEALTH AND WELLBEING OF OHL'S COMMUNITIES AND INCLUDE MEDICATION ASSISTED TREATMENT AND MEDICATION FOR OPIOID USE DISORDERS, COUNSELING, INDIVIDUALIZED CASE MANAGEMENT, PRIMARY AND OTHER PHYSICAL HEALTHCARE, AND RESIDENTIAL TREATMENT. OHL'S OVERDOSE TREATMENT ACCESS PROGRAM WILL EXPAND OPIOID-RELATED EDUCATION FOR HEALTHCARE AND SOCIAL SERVICES PROVIDERS IN LOUISIANA AND ACROSS THE COUNTRY. THROUGH A STRUCTURED CURRICULUM INFORMED BY INDUSTRY BEST PRACTICES AND CULTURAL HUMILITY, THIS PROGRAM WILL HELP PROVIDERS UNDERSTAND AND EMPATHIZE WITH THEIR PATIENTS WHILE LEARNING LIFE-SAVING ESSENTIALS ABOUT OPIOID USE AND OVERDOSES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/15/26 | ||
| Not listed | $0 | 1/13/26 | ||
| Not listed | $200.0k | 9/24/25 | ||
| Not listed | $200.0k | 9/24/25 | ||
| Not listed | $0 | 12/30/24 |